Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bares

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Nuklearmedizin. Nuclear Medicine|March 1, 1997
[A method for combined scatter and attenuation correction without transmission measurement for myocardial SPECT with 99m-Tc binding]J Kupferschläger, B Müller, G Schulz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2003
Non-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time-activity curvesM Reimold, W Mueller-Schauenburg, G A Becker, et al.
Nuklearmedizin. Nuclear Medicine|June 1, 1995
[MRI and oncoscintigraphy with 99m-Tc-MIBI in the follow up of thyroid cancer]M Biedermann, R Bares, B Grün, et al.
Skeletal Radiology|December 26, 2006
Unusual distribution of red marrow mimicking chloroma in a patient with acute myelogenous leukemiaM N Vogel, W Vogel, R Bares, et al.
Diagnostic and Interventional Imaging|September 17, 2013
Peptide receptor radionuclide therapy of neuroendocrine tumors with (90)Y-DOTATOC: is treatment response predictable by pre-therapeutic uptake of (68)Ga-DOTATOC?M Ö Öksüz, L Winter, C Pfannenberg, et al.
Onkologie|August 1, 1989
[Clinical significance of immunoscintigraphy for the diagnosis and treatment of gastrointestinal malignant tumors]R Bares, J Fass, G Weiller, et al.
Scandinavian Journal of Gastroenterology|September 20, 2000
Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinomaM Zimny, J Fass, R Bares, et al.
Nuklearmedizin. Nuclear Medicine|November 28, 2014
11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidismU Braeuning, C Pfannenberg, B Gallwitz, et al.
The International Journal of Biological Markers|April 1, 1989
A brief guide to the practice of radioimmunoscintigraphy and radioimmunotherapy in cancer. Report of the European Association of Nuclear Medicine Task Group on the clinical utility of labelled antibodiesK E Britton, G L Buraggi, R Bares, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2002
FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapyS M Eschmann, G Friedel, F Paulsen, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Nuklearmedizin. Nuclear Medicine|March 1, 1997
[A method for combined scatter and attenuation correction without transmission measurement for myocardial SPECT with 99m-Tc binding]J Kupferschläger, B Müller, G Schulz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2003
Non-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time-activity curvesM Reimold, W Mueller-Schauenburg, G A Becker, et al.
Nuklearmedizin. Nuclear Medicine|June 1, 1995
[MRI and oncoscintigraphy with 99m-Tc-MIBI in the follow up of thyroid cancer]M Biedermann, R Bares, B Grün, et al.
Skeletal Radiology|December 26, 2006
Unusual distribution of red marrow mimicking chloroma in a patient with acute myelogenous leukemiaM N Vogel, W Vogel, R Bares, et al.
Diagnostic and Interventional Imaging|September 17, 2013
Peptide receptor radionuclide therapy of neuroendocrine tumors with (90)Y-DOTATOC: is treatment response predictable by pre-therapeutic uptake of (68)Ga-DOTATOC?M Ö Öksüz, L Winter, C Pfannenberg, et al.
Onkologie|August 1, 1989
[Clinical significance of immunoscintigraphy for the diagnosis and treatment of gastrointestinal malignant tumors]R Bares, J Fass, G Weiller, et al.
Scandinavian Journal of Gastroenterology|September 20, 2000
Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinomaM Zimny, J Fass, R Bares, et al.
Nuklearmedizin. Nuclear Medicine|November 28, 2014
11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidismU Braeuning, C Pfannenberg, B Gallwitz, et al.
The International Journal of Biological Markers|April 1, 1989
A brief guide to the practice of radioimmunoscintigraphy and radioimmunotherapy in cancer. Report of the European Association of Nuclear Medicine Task Group on the clinical utility of labelled antibodiesK E Britton, G L Buraggi, R Bares, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2002
FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapyS M Eschmann, G Friedel, F Paulsen, et al.
Pageof 10